Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42933562)
Watch
English
More than just B-cell inhibition
scientific article published on 30 August 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
editorial
0 references
title
More than just B-cell inhibition
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
author
Eric M Ruderman
object named as
Eric M Ruderman
series ordinal
1
0 references
Richard M. Pope
object named as
Richard M Pope
series ordinal
2
0 references
publication date
30 August 2011
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
published in
Arthritis Research and Therapy
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
volume
13
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
issue
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
page(s)
125
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
cites work
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Bruton's tyrosine kinase is required for TLR-dependent heme oxygenase-1 gene activation via Nrf2 in macrophages
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
"Go upstream, young man": lessons learned from the p38 saga
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Tyrosine kinases and their substrates in B lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239370
retrieved
27 May 2018
Identifiers
DOI
10.1186/AR3439
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
Dimensions Publication ID
1020804046
0 references
PMC publication ID
3239370
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
PubMed publication ID
21878134
1 reference
stated in
Europe PubMed Central
PMC publication ID
3239370
retrieved
11 November 2017
ResearchGate publication ID
51606002
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
